Dose-Volume Comparison of Proton Radiotherapy and Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer
- Department of Medical Physics, Southern Tohoku Proton Therapy Center, Southern Tohoku Institute of Neuroscience, Koriyama, Fukushima (Japan)
- School of Health Sciences, Nagoya University, Nagoya, Aichi (Japan)
- Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Southern Tohoku Research Institute for Neuroscience, Koriyama, Fukushima (Japan)
Purpose: This study designed photon and proton treatment plans for patients treated with hypofractionated proton radiotherapy (PT) at the Southern Tohoku Proton Therapy Center (STPTC). We then calculated dosimetric parameters and compared results with simulated treatment plans for stereotactic body radiotherapy (SBRT), using dose--volume histograms to clearly explain differences in dose distributions between PT and SBRT. Methods and Materials: Twenty-one patients with stage I non-small-cell lung cancer (stage IA, n = 15 patients; stage IB, n = 6 patients) were studied. All tumors were located in the peripheral lung, and total dose was 66 Gray equivalents (GyE) (6.6 GyE/fraction). For treatment planning, beam incidence for proton beam technique was restricted to two to three directions for PT, and seven or eight noncoplanar beams were manually selected for SBRT to achieve optimal planning target volume (PTV) coverage and minimal dose to organs at risk. Results: Regarding lung tissues, mean dose, V5, V10, V13, V15, and V20 values were 4.6 Gy, 13.2%, 11.4%, 10.6%, 10.1%, and 9.1%, respectively, for PT, whereas those values were 7.8 Gy, 32.0%, 21.8%, 17.4%, 15.3%, and 11.4%, respectively, for SBRT with a prescribed dose of 66 Gy. Pearson product moment correlation coefficients between PTV and dose--volume parameters of V5, V10, V15, and V20 were 0.45, 0.52, 0.58, and 0.63, respectively, for PT, compared to 0.52, 0.45, 0.71, and 0.74, respectively, for SBRT. Conclusions: Correlations between dose--volume parameters of the lung and PTV were observed and may indicate that PT is more advantageous than SBRT when treating a tumor with a relatively large PTV or several tumors.
- OSTI ID:
- 21491654
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 79, Issue 4; Other Information: DOI: 10.1016/j.ijrobp.2010.05.016; PII: S0360-3016(10)00692-9; Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
A Dose-Volume Analysis of Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
Dose-Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer
Related Subjects
LUNGS
NEOPLASMS
PROTON BEAMS
PROTONS
RADIATION DOSE DISTRIBUTIONS
RADIATION DOSES
RADIOTHERAPY
BARYONS
BEAMS
BODY
DISEASES
DOSES
ELEMENTARY PARTICLES
FERMIONS
HADRONS
MEDICINE
NUCLEAR MEDICINE
NUCLEON BEAMS
NUCLEONS
ORGANS
PARTICLE BEAMS
RADIOLOGY
RESPIRATORY SYSTEM
THERAPY